Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma - January 2023

Safety and Efficacy of Engineered Toxin Body updates MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin’s Lymphomas and Diffuse Large B-cell Lymphoma – May 2022